NCT01658202View on ClinicalTrials.gov

Nicotine Patch Bioequivalence Study

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Healthy Smokers
Interventions
DRUG

V0116 transdermal patch (Test treatment )

DRUG

Nicotine transdermal patch (Reference Treatment )

Trial Locations (1)

Unknown

Rennes

All Listed Sponsors
lead

Pierre Fabre Medicament

INDUSTRY

NCT01658202 - Nicotine Patch Bioequivalence Study | Biotech Hunter | Biotech Hunter